{"id":16528,"date":"2015-08-03T16:50:42","date_gmt":"2015-08-03T21:50:42","guid":{"rendered":"https:\/\/www.rsslex.com\/actualites\/sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\/"},"modified":"2022-03-12T18:30:16","modified_gmt":"2022-03-12T23:30:16","slug":"20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field","status":"publish","type":"post","link":"https:\/\/www.rsslex.com\/en\/news\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\/","title":{"rendered":"Sharon Druker closes a transaction in the pharmaceuticals field"},"content":{"rendered":"<p><!-- August 3, 2015&nbsp;&mdash; -->On June 22, Gladius Pharmaceuticals Inc., a new Montr\u00e9al-based biotechnology firm, announced the closing of the equity financing via a cross-border vehicle of US technology developed by Sopharmia Inc. This investment will support Gladius\u2019 development of novel drugs destined to treat major multi-drug-resistant bacterial infections.<\/p>\n<p><a href=\"\/en\/team\/sharon-g-druker\/\">Sharon G. Druker<\/a> represented Sopharmia and Gladius on the deal, which also involved SR One (GlaxoSmithKline\u2019s venture capital fund) and Lumira (Merck Lumira\u2019s venture capital fund), as well as the Fonds de solidarit\u00e9 FTQ.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On June 22, Gladius Pharmaceuticals Inc., a new Montr\u00e9al-based biotechnology firm, announced the closing of the equity financing via a cross-border vehicle of US technology developed by Sopharmia Inc. This investment will support Gladius\u2019 development of novel drugs destined to treat major multi-drug-resistant bacterial infections. Sharon G. Druker represented Sopharmia and Gladius on the deal, [&hellip;]<\/p>\n","protected":false},"author":18,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49,232],"tags":[],"class_list":["post-16528","post","type-post","status-publish","format-standard","hentry","category-news","category-business-law"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sharon Druker closes a transaction in the pharmaceuticals field - RSS - Robinson Sheppard Shapiro<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rsslex.com\/en\/news\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sharon Druker closes a transaction in the pharmaceuticals field - RSS - Robinson Sheppard Shapiro\" \/>\n<meta property=\"og:description\" content=\"On June 22, Gladius Pharmaceuticals Inc., a new Montr\u00e9al-based biotechnology firm, announced the closing of the equity financing via a cross-border vehicle of US technology developed by Sopharmia Inc. This investment will support Gladius\u2019 development of novel drugs destined to treat major multi-drug-resistant bacterial infections. Sharon G. Druker represented Sopharmia and Gladius on the deal, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rsslex.com\/en\/news\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\/\" \/>\n<meta property=\"og:site_name\" content=\"RSS - Robinson Sheppard Shapiro\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/rsslex\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-08-03T21:50:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-12T23:30:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rsslex.com\/wp-content\/uploads\/2022\/03\/Placeholder-News.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"V\u00e9ronique Nollet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"V\u00e9ronique Nollet\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rsslex.com\\\/en\\\/news\\\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rsslex.com\\\/en\\\/news\\\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\\\/\"},\"author\":{\"name\":\"V\u00e9ronique Nollet\",\"@id\":\"https:\\\/\\\/www.rsslex.com\\\/en\\\/#\\\/schema\\\/person\\\/0d1c0fa6dcd13392d3db5c5246c97d9d\"},\"headline\":\"Sharon Druker closes a transaction in the pharmaceuticals field\",\"datePublished\":\"2015-08-03T21:50:42+00:00\",\"dateModified\":\"2022-03-12T23:30:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rsslex.com\\\/en\\\/news\\\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\\\/\"},\"wordCount\":90,\"articleSection\":[\"Announcements\",\"Business Law\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rsslex.com\\\/en\\\/news\\\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\\\/\",\"url\":\"https:\\\/\\\/www.rsslex.com\\\/en\\\/news\\\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\\\/\",\"name\":\"Sharon Druker closes a transaction in the pharmaceuticals field - RSS - Robinson Sheppard Shapiro\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rsslex.com\\\/en\\\/#website\"},\"datePublished\":\"2015-08-03T21:50:42+00:00\",\"dateModified\":\"2022-03-12T23:30:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.rsslex.com\\\/en\\\/#\\\/schema\\\/person\\\/0d1c0fa6dcd13392d3db5c5246c97d9d\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rsslex.com\\\/en\\\/news\\\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rsslex.com\\\/en\\\/news\\\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rsslex.com\\\/en\\\/news\\\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"RSS\",\"item\":\"https:\\\/\\\/www.rsslex.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sharon Druker closes a transaction in the pharmaceuticals field\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rsslex.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.rsslex.com\\\/en\\\/\",\"name\":\"RSS - Robinson Sheppard Shapiro\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rsslex.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rsslex.com\\\/en\\\/#\\\/schema\\\/person\\\/0d1c0fa6dcd13392d3db5c5246c97d9d\",\"name\":\"V\u00e9ronique Nollet\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/af968db4245bdb856024dfe4e11f0e5e1840e95112c36381c59713dc230c3a3c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/af968db4245bdb856024dfe4e11f0e5e1840e95112c36381c59713dc230c3a3c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/af968db4245bdb856024dfe4e11f0e5e1840e95112c36381c59713dc230c3a3c?s=96&d=mm&r=g\",\"caption\":\"V\u00e9ronique Nollet\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sharon Druker closes a transaction in the pharmaceuticals field - RSS - Robinson Sheppard Shapiro","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rsslex.com\/en\/news\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\/","og_locale":"en_US","og_type":"article","og_title":"Sharon Druker closes a transaction in the pharmaceuticals field - RSS - Robinson Sheppard Shapiro","og_description":"On June 22, Gladius Pharmaceuticals Inc., a new Montr\u00e9al-based biotechnology firm, announced the closing of the equity financing via a cross-border vehicle of US technology developed by Sopharmia Inc. This investment will support Gladius\u2019 development of novel drugs destined to treat major multi-drug-resistant bacterial infections. Sharon G. Druker represented Sopharmia and Gladius on the deal, [&hellip;]","og_url":"https:\/\/www.rsslex.com\/en\/news\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\/","og_site_name":"RSS - Robinson Sheppard Shapiro","article_publisher":"https:\/\/www.facebook.com\/rsslex\/","article_published_time":"2015-08-03T21:50:42+00:00","article_modified_time":"2022-03-12T23:30:16+00:00","og_image":[{"width":1000,"height":500,"url":"https:\/\/www.rsslex.com\/wp-content\/uploads\/2022\/03\/Placeholder-News.png","type":"image\/png"}],"author":"V\u00e9ronique Nollet","twitter_card":"summary_large_image","twitter_misc":{"Written by":"V\u00e9ronique Nollet"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rsslex.com\/en\/news\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\/#article","isPartOf":{"@id":"https:\/\/www.rsslex.com\/en\/news\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\/"},"author":{"name":"V\u00e9ronique Nollet","@id":"https:\/\/www.rsslex.com\/en\/#\/schema\/person\/0d1c0fa6dcd13392d3db5c5246c97d9d"},"headline":"Sharon Druker closes a transaction in the pharmaceuticals field","datePublished":"2015-08-03T21:50:42+00:00","dateModified":"2022-03-12T23:30:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rsslex.com\/en\/news\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\/"},"wordCount":90,"articleSection":["Announcements","Business Law"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rsslex.com\/en\/news\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\/","url":"https:\/\/www.rsslex.com\/en\/news\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\/","name":"Sharon Druker closes a transaction in the pharmaceuticals field - RSS - Robinson Sheppard Shapiro","isPartOf":{"@id":"https:\/\/www.rsslex.com\/en\/#website"},"datePublished":"2015-08-03T21:50:42+00:00","dateModified":"2022-03-12T23:30:16+00:00","author":{"@id":"https:\/\/www.rsslex.com\/en\/#\/schema\/person\/0d1c0fa6dcd13392d3db5c5246c97d9d"},"breadcrumb":{"@id":"https:\/\/www.rsslex.com\/en\/news\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rsslex.com\/en\/news\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rsslex.com\/en\/news\/20150803_sharon-druker-closes-a-transaction-in-the-pharmaceuticals-field\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"RSS","item":"https:\/\/www.rsslex.com\/en\/"},{"@type":"ListItem","position":2,"name":"Sharon Druker closes a transaction in the pharmaceuticals field"}]},{"@type":"WebSite","@id":"https:\/\/www.rsslex.com\/en\/#website","url":"https:\/\/www.rsslex.com\/en\/","name":"RSS - Robinson Sheppard Shapiro","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rsslex.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.rsslex.com\/en\/#\/schema\/person\/0d1c0fa6dcd13392d3db5c5246c97d9d","name":"V\u00e9ronique Nollet","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/af968db4245bdb856024dfe4e11f0e5e1840e95112c36381c59713dc230c3a3c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/af968db4245bdb856024dfe4e11f0e5e1840e95112c36381c59713dc230c3a3c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/af968db4245bdb856024dfe4e11f0e5e1840e95112c36381c59713dc230c3a3c?s=96&d=mm&r=g","caption":"V\u00e9ronique Nollet"}}]}},"views":206,"_links":{"self":[{"href":"https:\/\/www.rsslex.com\/en\/wp-json\/wp\/v2\/posts\/16528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rsslex.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rsslex.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rsslex.com\/en\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rsslex.com\/en\/wp-json\/wp\/v2\/comments?post=16528"}],"version-history":[{"count":3,"href":"https:\/\/www.rsslex.com\/en\/wp-json\/wp\/v2\/posts\/16528\/revisions"}],"predecessor-version":[{"id":22468,"href":"https:\/\/www.rsslex.com\/en\/wp-json\/wp\/v2\/posts\/16528\/revisions\/22468"}],"wp:attachment":[{"href":"https:\/\/www.rsslex.com\/en\/wp-json\/wp\/v2\/media?parent=16528"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rsslex.com\/en\/wp-json\/wp\/v2\/categories?post=16528"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rsslex.com\/en\/wp-json\/wp\/v2\/tags?post=16528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}